{"id":"https://openalex.org/W4399080411","doi":"https://doi.org/10.1080/17460441.2024.2360415","title":"Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis","display_name":"Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis","alternate_titles":[],"publication_year":2024,"publication_date":"2024-05-28","ids":{"openalex":"https://openalex.org/W4399080411","doi":"https://doi.org/10.1080/17460441.2024.2360415","pmid":"https://pubmed.ncbi.nlm.nih.gov/38804735"},"language":"en","primary_location":{"id":"doi:10.1080/17460441.2024.2360415","doi":"https://doi.org/10.1080/17460441.2024.2360415","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17460441.2024.2360415","pdf_url":null,"source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4399080411"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083341734","display_name":"Donatos Tsamoulis","orcid":"https://orcid.org/0000-0001-8752-1869","observed_orcids":["https://orcid.org/0000-0001-8752-1869"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"Donatos Tsamoulis","raw_affiliation_strings":["Second Department of Cardiology, National & Kapodistrian University of Athens, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Cardiology, National & Kapodistrian University of Athens, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035360425","display_name":"L\u03bfukianos S. Rallidis","orcid":"https://orcid.org/0000-0002-7349-0309","observed_orcids":["https://orcid.org/0000-0002-7349-0309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Loukianos S. Rallidis","raw_affiliation_strings":["View further author information"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"View further author information","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011051172","display_name":"Constantine E. Kosmas","orcid":"https://orcid.org/0000-0003-3926-0304","observed_orcids":["https://orcid.org/0000-0003-3926-0304"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Constantine E. Kosmas","raw_affiliation_strings":["Second Department of Cardiology, National & Kapodistrian University of Athens, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Cardiology, National & Kapodistrian University of Athens, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083341734"],"corresponding_institution_ids":["https://openalex.org/I200777214"],"apc_list":null,"apc_paid":null,"fwci":0.2672,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.29314111,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"19","issue":"7","first_page":"773","last_page":"782"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inclisiran","display_name":"inclisiran","score":1.0},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.8930000066757202},{"id":"https://openalex.org/keywords/pcsk9","display_name":"PCSK9","score":0.7929999828338623},{"id":"https://openalex.org/keywords/sirna","display_name":"siRNA","score":0.9419999718666077},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8330000042915344},{"id":"https://openalex.org/keywords/post-transcriptional-gene-silencing","display_name":"post-transcriptional gene silencing","score":0.9200000166893005},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.875},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.6810559630393982},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.6610379219055176},{"id":"https://openalex.org/C22615655","wikidata":"https://www.wikidata.org/wiki/Q203221","display_name":"Small interfering RNA","level":4,"score":0.5907630324363708},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5881119966506958},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.5828527808189392},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5162529945373535},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.5067639946937561},{"id":"https://openalex.org/C2909478654","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Atherosclerotic cardiovascular disease","level":3,"score":0.44210106134414673},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.4232098460197449},{"id":"https://openalex.org/C2777704780","wikidata":"https://www.wikidata.org/wiki/Q21115210","display_name":"ABCA1","level":4,"score":0.41815388202667236},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.34308096766471863},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32696089148521423},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.29875701665878296},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2830365300178528},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.24775859713554382},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.22031164169311523},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19584691524505615},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10152891278266907},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D020868","descriptor_name":"Gene Silencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/17460441.2024.2360415","doi":"https://doi.org/10.1080/17460441.2024.2360415","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17460441.2024.2360415","pdf_url":null,"source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},{"id":"pmid:38804735","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38804735","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug discovery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1520609538","https://openalex.org/W1647075334","https://openalex.org/W1948458971","https://openalex.org/W1990548509","https://openalex.org/W2040612932","https://openalex.org/W2078669364","https://openalex.org/W2100932663","https://openalex.org/W2101185950","https://openalex.org/W2110083155","https://openalex.org/W2141137217","https://openalex.org/W2164089346","https://openalex.org/W2496954959","https://openalex.org/W2555483953","https://openalex.org/W2595169180","https://openalex.org/W2596179513","https://openalex.org/W2630192492","https://openalex.org/W2769031591","https://openalex.org/W2883175571","https://openalex.org/W2899997727","https://openalex.org/W2903347258","https://openalex.org/W2932523428","https://openalex.org/W2955200437","https://openalex.org/W2976144989","https://openalex.org/W2980761229","https://openalex.org/W2980989947","https://openalex.org/W3011005820","https://openalex.org/W3012265841","https://openalex.org/W3031154470","https://openalex.org/W3096580040","https://openalex.org/W3128956245","https://openalex.org/W3130622571","https://openalex.org/W3162624947","https://openalex.org/W3165627834","https://openalex.org/W3183857127","https://openalex.org/W3208891341","https://openalex.org/W4205949466","https://openalex.org/W4211127626","https://openalex.org/W4220912720","https://openalex.org/W4237041690","https://openalex.org/W4281255296","https://openalex.org/W4283159554","https://openalex.org/W4307777231","https://openalex.org/W4311309800","https://openalex.org/W4313554841","https://openalex.org/W4365146108","https://openalex.org/W4383058488","https://openalex.org/W4386153206","https://openalex.org/W4386836462","https://openalex.org/W4387728648","https://openalex.org/W4388115444"],"related_works":["https://openalex.org/W4387607997","https://openalex.org/W4283747817","https://openalex.org/W3093906897","https://openalex.org/W4416664719","https://openalex.org/W4393314184","https://openalex.org/W4327595480","https://openalex.org/W7165192369","https://openalex.org/W4392594886","https://openalex.org/W4403383942","https://openalex.org/W4318485162"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Atherosclerotic":[1],"cardiovascular":[2],"disease":[3],"(ASCVD)":[4],"remains":[5],"a":[6,47],"leading":[7,78],"cause":[8],"of":[9,21,41,84,143,158,180,185,199],"global":[10],"morbidity":[11],"and":[12,24,77,109,132,141,146,176],"mortality.":[13],"Lipid":[14],"lowering":[15,53],"therapy":[16],"(LLT)":[17],"constitutes":[18],"the":[19,65,85,130,135,138,148,170],"cornerstone":[20],"ASCVD":[22,174],"prevention":[23,175],"treatment.":[25],"However,":[26],"several":[27],"patients":[28],"fail":[29],"to":[30,35,56,79,125,168,172],"achieve":[31],"therapeutic":[32],"goals":[33],"due":[34],"low":[36],"treatment":[37],"adherence":[38],"or":[39],"limitations":[40],"standard-of-care":[42],"(SoC)":[43],"LLTs.":[44],"Inclisiran":[45,166],"represents":[46],"pivotal":[48],"low-density":[49],"lipoprotein":[50],"cholesterol":[51],"(LDL-C)":[52],"agent":[54,145],"aiming":[55],"address":[57],"current":[58],"unmet":[59],"needs":[60],"in":[61,99,164],"LLT.":[62],"It":[63],"is":[64],"first":[66],"available":[67],"small":[68],"interfering":[69],"RNA":[70],"(siRNA)":[71],"LLT,":[72],"specifically":[73],"targeting":[74],"PCSK9":[75,86],"mRNA":[76],"post-transcriptional":[80],"gene":[81],"silencing":[82],"(PTGS)":[83],"gene.":[87],"AREAS":[88],"COVERED:":[89],"Promising":[90],"phase":[91],"III":[92],"trials":[93],"revealed":[94],"an":[95],"~":[96],"50%":[97],"reduction":[98],"LDL-C":[100],"levels":[101],"with":[102,117,150],"subcutaneous":[103],"inclisiran":[104],"administration":[105],"on":[106],"days":[107],"1":[108],"90,":[110],"followed":[111],"by":[112,128],"semiannual":[113],"booster":[114],"shots.":[115],"Coupled":[116],"inclisiran's":[118],"favorable":[119],"safety":[120],"profile,":[121],"these":[122],"findings":[123],"led":[124],"its":[126],"approval":[127],"both":[129],"EMA":[131],"FDA.":[133],"Herein,":[134],"authors":[136],"highlight":[137],"preclinical":[139],"discovery":[140],"development":[142],"this":[144],"provide":[147],"reader":[149],"their":[151],"expert":[152],"perspectives.":[153],"EXPERT":[154],"OPINION:":[155],"The":[156],"evolution":[157],"gene-silencing":[159],"treatments":[160],"offers":[161],"new":[162],"perspectives":[163],"therapeutics.":[165],"appears":[167],"have":[169],"potential":[171],"revolutionize":[173],"treatment,":[177],"benefiting":[178],"millions":[179],"patients.":[181],"Ensuring":[182],"widespread":[183],"availability":[184],"Inclisiran,":[186],"as":[187,189],"well":[188],"managing":[190],"additional":[191],"healthcare":[192],"costs":[193],"that":[194],"may":[195],"arise,":[196],"should":[197],"be":[198],"paramount":[200],"importance.":[201]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4399080411","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-05-29T00:00:00"}
